50 results on '"Guerriero, Carla"'
Search Results
2. Young people' s willingness to pay for environmental protection
- Author
-
Dardanoni, Valentino and Guerriero, Carla
- Published
- 2021
- Full Text
- View/download PDF
3. Using Animation to Self-Report Health: A Randomized Experiment with Children
- Author
-
Guerriero, Carla, Jaume, Neus Abrines, Diaz-Ordaz, Karla, Brown, Katherine Loraine, Wray, Jo, Ashworth, Joan, Abbiss, Matt, and Cairns, John
- Published
- 2020
- Full Text
- View/download PDF
4. Analyzing matching patterns in marriage: Theory and application to Italian data.
- Author
-
Chiappori, Pierre‐André, Ciscato, Edoardo, and Guerriero, Carla
- Subjects
HUMAN capital ,EXTREME value theory ,RELATIONSHIP quality ,GENERATING functions ,PERCEIVED quality - Abstract
Social scientists have long been interested in marital homogamy and its relationship with inequality. However, measuring homogamy is not straightforward, particularly when one is interested in assessing marital sorting based on multiple traits. In this paper, we argue that Separate Extreme Value (SEV) models not only generate a matching function with several desirable theoretical properties, but they are also suited for the study of multidimensional sorting. Specifically, we use rich small‐scale survey data to examine sorting among parents of school‐age children in Naples. We show that homogamy is pervasive; not only do men and women sort by age, education, and physical characteristics, but they also look for partners that share similar health‐related behavior and risk attitude. However, we also show that these marital patterns are well explained by a low number of dimensions, the most important being age cohort and human capital. In particular, human capital relates to various "outcomes" of the post‐matching relationship. Children of parents with a high human capital endowment perform better at school, although they report lower levels of subjective well‐being and of perceived quality of relationship with their mothers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Health and sustainability in post-pandemic economic policies
- Author
-
Guerriero, Carla, Haines, Andy, and Pagano, Marco
- Published
- 2020
- Full Text
- View/download PDF
6. The economic benefits of reducing the levels of nitrogen dioxide (NO2) near primary schools: The case of London
- Author
-
Guerriero, Carla, Chatzidiakou, Lia, Cairns, John, and Mumovic, Dejan
- Published
- 2016
- Full Text
- View/download PDF
7. Author Correction: Health and sustainability in post-pandemic economic policies
- Author
-
Guerriero, Carla, Haines, Andy, and Pagano, Marco
- Published
- 2020
- Full Text
- View/download PDF
8. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop
- Author
-
Guerriero, Carla, Cairns, John, Roberts, Ian, Rodgers, Anthony, Whittaker, Robyn, and Free, Caroline
- Published
- 2013
9. Verteporfin Photodynamic Therapy Cohort Study: Report 2: Clinical Measures of Vision and Health-Related Quality of Life
- Author
-
Reeves, Barnaby C., Langham, Julia, Walker, Jemma, Grieve, Richard, Chakravarthy, Usha, Tomlin, Keith, Carpenter, James, Guerriero, Carla, and Harding, Simon P.
- Published
- 2009
- Full Text
- View/download PDF
10. Verteporfin Photodynamic Therapy Cohort Study: Report 3: Cost Effectiveness and Lessons for Future Evaluations
- Author
-
Grieve, Richard, Guerriero, Carla, Walker, Jemma, Tomlin, Keith, Langham, Julia, Harding, Simon, Chakravathy, Usha, Carpenter, James, and Reeves, Barnaby C.
- Published
- 2009
- Full Text
- View/download PDF
11. Chapter 12 - Conclusion
- Author
-
Guerriero, Carla and Wright, John S.F.
- Published
- 2020
- Full Text
- View/download PDF
12. Chapter 11 - Case study: a realistic contaminated site remediation and different scenarios of intervention
- Author
-
Guerriero, Carla, Papirio, Stefano, Pirozzi, Francesco, Ranzi, Andrea, Rebolledo, L.E. Loria, and Watson, Verity
- Published
- 2020
- Full Text
- View/download PDF
13. Chapter 7 - Discounting benefits and costs
- Author
-
Guerriero, Carla and Pacelli, Antonia
- Published
- 2020
- Full Text
- View/download PDF
14. Chapter 6 - Costing environmental health intervention
- Author
-
Guerriero, Carla
- Published
- 2020
- Full Text
- View/download PDF
15. Chapter 1 - The key steps in cost–benefit analysis of environmental health interventions
- Author
-
Guerriero, Carla
- Published
- 2020
- Full Text
- View/download PDF
16. The risk of transfusion-transmitted infections in sub-Saharan Africa
- Author
-
Jayaraman, Sudha, Chalabi, Zaid, Perel, Pablo, Guerriero, Carla, and Roberts, Ian
- Published
- 2010
- Full Text
- View/download PDF
17. Policies to clean up toxic industrial contaminated sites of Gela and Priolo: a cost-benefit analysis
- Author
-
Cairns John, Bianchi Fabrizio, Guerriero Carla, and Cori Liliana
- Subjects
Industrial medicine. Industrial hygiene ,RC963-969 ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Cost-benefit analysis is a transparent tool to inform policy makers about the potential effect of regulatory interventions, nevertheless its use to evaluate clean-up interventions in polluted industrial sites is limited. The two industrial areas of Gela and Priolo in Italy were declared "at high risk of environmental crisis" in 1990. Since then little has been done to clean the polluted sites and reduce the health outcomes attributable to pollution exposure. This study, aims to quantify the monetary benefits resulting from clean-up interventions in the contaminated sites of Gela and Priolo. Methods A damage function approach was used to estimate the number of health outcomes attributable to industrial pollution exposure. Extensive one way analyses and probabilistic analyses were conducted to investigate the sensitivity of results to different model assumptions. Results It has been estimated that, on average, 47 cases of premature death, 281 cases of cancer and 2,702 cases of non-cancer hospital admission could be avoided each year by removing environmental exposure in these two areas. Assuming a 20 year cessation lag and a 4% discount rate we calculate that the potential monetary benefit of removing industrial pollution is €3,592 million in Priolo and €6,639 million in Gela. Conclusions Given the annual number of health outcomes attributable to pollution exposure the effective clean-up of Gela and Priolo should be prioritised. This study suggests that clean-up policies costing up to €6,639 million in Gela and €3,592 million in Priolo would be cost beneficial. These two amounts are notably higher than the funds allocated thus far to clean up the two sites, €127.4 million in Gela and €774.5 million in Priolo, implying that further economic investments - even considerable ones - could still prove cost beneficial.
- Published
- 2011
- Full Text
- View/download PDF
18. Is computer aided detection (CAD) cost effective in screening mammography? A model based on the CADET II study
- Author
-
Wallis Matthew G, Cairns John, Gillan Maureen GC, Guerriero Carla, and Gilbert Fiona J
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Single reading with computer aided detection (CAD) is an alternative to double reading for detecting cancer in screening mammograms. The aim of this study is to investigate whether the use of a single reader with CAD is more cost-effective than double reading. Methods Based on data from the CADET II study, the cost-effectiveness of single reading with CAD versus double reading was measured in terms of cost per cancer detected. Cost (Pound (£), year 2007/08) of single reading with CAD versus double reading was estimated assuming a health and social service perspective and a 7 year time horizon. As the equipment cost varies according to the unit size a separate analysis was conducted for high, average and low volume screening units. One-way sensitivity analyses were performed by varying the reading time, equipment and assessment cost, recall rate and reader qualification. Results CAD is cost increasing for all sizes of screening unit. The introduction of CAD is cost-increasing compared to double reading because the cost of CAD equipment, staff training and the higher assessment cost associated with CAD are greater than the saving in reading costs. The introduction of single reading with CAD, in place of double reading, would produce an additional cost of £227 and £253 per 1,000 women screened in high and average volume units respectively. In low volume screening units, the high cost of purchasing the equipment will results in an additional cost of £590 per 1,000 women screened. One-way sensitivity analysis showed that the factors having the greatest effect on the cost-effectiveness of CAD with single reading compared with double reading were the reading time and the reader's professional qualification (radiologist versus advanced practitioner). Conclusions Without improvements in CAD effectiveness (e.g. a decrease in the recall rate) CAD is unlikely to be a cost effective alternative to double reading for mammography screening in UK. This study provides updated estimates of CAD costs in a full-field digital system and assessment cost for women who are re-called after initial screening. However, the model is highly sensitive to various parameters e.g. reading time, reader qualification, and equipment cost.
- Published
- 2011
- Full Text
- View/download PDF
19. Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation
- Author
-
Perel Pablo, Roberts Ian, Jayaraman Sudha, Cairns John, Guerriero Carla, and Shakur Haleema
- Subjects
Medicine (General) ,R5-920 - Abstract
Abstract Background The identification of safe and effective alternatives to blood transfusion is a public health priority. In sub-Saharan Africa, blood shortage is a cause of mortality and morbidity. Blood transfusion can also transmit viral infections. Giving tranexamic acid (TXA) to bleeding surgical patients has been shown to reduce both the number of blood transfusions and the volume of blood transfused. The objective of this study is to investigate whether routinely administering TXA to bleeding elective surgical patients is cost effective by both averting deaths occurring from the shortage of blood, and by preventing infections from blood transfusions. Methods A decision tree was constructed to evaluate the cost-effectiveness of providing TXA compared with no TXA in patients with surgical bleeding in four African countries with different human immunodeficiency virus (HIV) prevalence and blood donation rates (Kenya, South Africa, Tanzania and Botswana). The principal outcome measures were cost per life saved and cost per infection averted (HIV, Hepatitis B, Hepatitis C) averted in 2007 International dollars ($). The probability of receiving a blood transfusion with and without TXA and the risk of blood borne viral infection were estimated. The impact of uncertainty in model parameters was explored using one-way deterministic sensitivity analyses. Probabilistic sensitivity analysis was performed using Monte Carlo simulation. Results The incremental cost per life saved is $87 for Kenya and $93 for Tanzania. In Botswana and South Africa, TXA administration is not life saving but is highly cost saving since fewer units of blood are transfused. Further, in Botswana the administration of TXA averts one case of HIV and four cases of Hepatitis B (HBV) per 1,000 surgical patients. In South Africa, one case of HBV is averted per 1,000 surgical patients. Probabilistic sensitivity analyses confirmed the robustness of the model. Conclusion An economic argument can be made for giving TXA to bleeding elective surgical patients. In countries where there is a blood shortage, TXA would be a cost effective way to reduce mortality. In countries where there is no blood shortage, TXA would reduce healthcare costs and avert blood borne infections.
- Published
- 2010
- Full Text
- View/download PDF
20. The potential monetary benefits of reclaiming hazardous waste sites in the Campania region: an economic evaluation
- Author
-
Cairns John and Guerriero Carla
- Subjects
Industrial medicine. Industrial hygiene ,RC963-969 ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Evaluating the economic benefit of reducing negative health outcomes resulting from waste management is of pivotal importance for designing an effective waste policy that takes into account the health consequences for the populations exposed to environmental hazards. Despite the high level of Italian and international media interest in the problem of hazardous waste in Campania little has been done to reclaim the land and the waterways contaminated by hazardous waste. Objective This study aims to reduce the uncertainty about health damage due to waste exposure by providing for the first time a monetary valuation of health benefits arising from the reclamation of hazardous waste dumps in Campania. Methods First the criteria by which the landfills in the Campania region, in particular in the two provinces of Naples and Caserta, have been classified are described. Then, the annual cases of premature death and fatal cases of cancers attributable to waste exposure are quantified. Finally, the present value of the health benefits from the reclamation of polluted land is estimated for each of the health outcomes (premature mortality, fatal cancer and premature mortality adjusted for the cancer premium). Due to the uncertainty about the time frame of the benefits arising from reclamation, the latency of the effects of toxic waste on human health and the lack of context specific estimates of the Value of Preventing a Fatality (VPF), extensive sensitivity analyses are performed. Results There are estimated to be 848 cases of premature mortality and 403 cases of fatal cancer per year as a consequence of exposure to toxic waste. The present value of the benefit of reducing the number of waste associated deaths after adjusting for a cancer premium is €11.6 billion. This value ranges from €5.4 to €20.0 billion assuming a time frame for benefits of 10 and 50 years respectively. Conclusion This study suggests that there is a strong economic argument for both reclaiming the land contaminated with hazardous waste in the two provinces of Naples and Caserta and increasing the control of the territory in order to avoid the creation of new illegal dump sites.
- Published
- 2009
- Full Text
- View/download PDF
21. Are children rational decision makers when they are asked to value their own health? A contingent valuation study conducted with children and their parents.
- Author
-
Guerriero, Carla, Cairns, John, Bianchi, Fabrizio, and Cori, Liliana
- Abstract
Despite the importance of including children's preferences in the valuation of their own health benefits, no study has investigated the ability of children to understand willingness-to-pay (WTP) questions. Using a contingent valuation method, we elicit children's and parents' WTP to reduce children's risk of an asthma attack. Our results suggest that children are able to understand and value their own health risk reductions, and their ability to do so improves with age. Child age was found to be inversely related to parents' and children's WTP. The results also suggest that non-paternalistic altruism is predictive of children's WTP. For parents, care for their own health was found to be inversely related with their WTP for children's risk reductions. Comparison of parents' and children's WTP suggests that parents are willing to sacrifice for their child's health risk reduction an amount that is approximately twice that of their children. The analysis of matched pairs of parents and children suggest that there are within-household similarities as the child's WTP is positively related to parents' WTP. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
22. Cost-Benefit Analysis of the Clean-Up of Hazardous Waste Sites
- Author
-
Guerriero, Carla
- Subjects
Technology & Engineering / Civil - Abstract
Cost-Benefit Analysis of the Clean-Up of Hazardous Waste Sites
- Published
- 2011
23. The dog was acting: Designing an animation tool to enable children and young people to express their views about their health state.
- Author
-
ABBISS, MATT, ASHWORTH, JOAN, ABRINES, NEUS, CAIRNS, JOHN, WRAY, JO, BROWN, KATHERINE, and GUERRIERO, CARLA
- Subjects
CHILDREN'S health ,CHILD psychology ,ANIMATION (Cinematography) ,MEDICAL informatics ,INSOMNIA - Abstract
Children's Health State Preferences Learnt from Animation (CHILDSPLA) is an innovative, multidisciplinary collaboration between the London School of Hygiene and Tropical Medicine, Great Ormond Street Hospital and the Royal College of Art, London. The team came together to develop an animated iPad app aiming to measure the health states of children, designed to gather key data directly from them rather than through a parent or carer. Successful development of a child-friendly method for collecting health information directly from children would add considerably to the ability to measure outcomes and evaluate the effectiveness of treatments. It was expected that the app would allow children as young as 4 years old to express their views, not only because it required lower literacy competencies but also because it would be more engaging. For example, the app was designed to ask the child, 'on a scale of 1-5 how much pain are you in today?' but, rather than text or voice, the app showed animated representations of pain, sleeplessness and annoyance, etc. Children were involved from the outset in the design of the character and the animation performances., The style of the animation needed to be tested by the young target users to observe their responses to different styles of animated performance. Some children observed that some animation characters were acting in an exaggerated way, for comic effect, and this distanced them from empathizing with the expressed emotion, as it was not seen as genuine. This led the animator to steer away from broad and exaggerated animation in order to chase engagement and stay closer to subtler, more naturalistic performances. The animated prototype app was tested by both sick and healthy children against other forms of gathering data. The CHILDSPLA team discussed and reflected on the challenges and knowledge emerging during the first year of the Medical Research Council-funded project. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
24. List of contributors
- Author
-
Chalabi, Zaid, George, Frank, Guerriero, Carla, Lauriola, Paolo, Leonardi, Giovanni, Luchini, Stéphane, Martuzzi, Marco, Pacelli, Antonia, Papirio, Stefano, Pirozzi, Francesco, Ranzi, Andrea, Rebolledo, L.E. Loria, Regier, Dean, Schulz, Rainer, Watson, Verity, Wright, John S.F., and Zeka, Ariana
- Published
- 2020
- Full Text
- View/download PDF
25. Practical Guide to Document Authentication: Legalization of Notarized and Certified Documents.
- Author
-
Guerriero, Carla
- Subjects
Practical Guide to Document Authentication: Legalization of Notarized and Certified Documents (Book) -- Sinnott, John P. ,Books -- Book reviews - Abstract
Practical Guide to Document Authentication: Legalization of Notarized and Certified Documents. John P. Sinnott. 2005. Oceana Publications, Inc. Hardcover. 732p. ISBN: 0-379-2127-7. $165. The phrase "document authentication" refers to the [...]
- Published
- 2005
26. Wasting lives: The effects of toxic waste exposure on health.
- Author
-
Barba, Maddalena, Mazza, Alfredo, Guerriero, Carla, Di Maio, Massimo, Romeo, Frank, Maranta, Pasquale, Marino, Ignazio R., Paggi, Marco G., and Giordano, Antonio
- Published
- 2011
- Full Text
- View/download PDF
27. Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial.
- Author
-
Guerriero, Carla, Cairns, John, Perel, Pablo, Shakur, Haleema, and Roberts, Ian
- Subjects
- *
HEMORRHAGE , *MARKOV processes , *COST effectiveness , *SENSITIVITY analysis - Abstract
Objective: To assess the cost effectiveness of giving tranexamic acid (TXA) to bleeding trauma patients in low, middle and high income settings. Methods: The CRASH-2 trial showed that TXA administration reduces the risk of death in bleeding trauma patients with a small but statistically significant increase in non-intensive care stay. A Markov model was used to assess the cost effectiveness of TXA in Tanzania, India and the United Kingdom (UK). The health outcome was the number of life years gained (LYs). Two costs were considered: the cost of administering TXA and the cost of additional days in hospital. Cost data were obtained from hospitals, World Health Organization (WHO) database and UK reference costs. Cost-effectiveness was measured in international dollars ($) per LY. Both deterministic and probabilistic sensitivity analyses were performed to test the robustness of the results to model assumptions. Findings: Administering TXA to bleeding trauma patients within three hours of injury saved an estimated 372, 315 and 755 LYs per 1,000 trauma patients in Tanzania, India and the UK respectively. The cost of giving TXA to 1,000 patients was $17,483 in Tanzania, $19,550 in India and $30,830 in the UK. The incremental cost of giving TXA versus not giving TXA was $18,025 in Tanzania, $20,670 in India and $48,002 in the UK. The estimated incremental cost per LY gained of administering TXA is $48, $66 and $64 in Tanzania, India and the UK respectively. Conclusion: Early administration of TXA to bleeding trauma patients is likely to be highly cost effective in low, middle and high income settings. Trial Registration: This paper uses data collected by the CRASH 2 trial: Controlled-Trials.com ISRCTN86750102, Clinicaltrials. gov NCT00375258 and South African Clinical Trial Register DOH-27-0607-1919. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
28. Is computer aided detection (CAD) cost effective in screening mammography? A model based on the CADET II study.
- Author
-
Guerriero, Carla, Gillan, Maureen G. C., Cairns, John, Wallis, Matthew G., and Gilbert, Fiona J.
- Subjects
- *
CANCER diagnosis , *MAMMOGRAMS , *BREAST exams , *MEDICAL care costs - Abstract
Background: Single reading with computer aided detection (CAD) is an alternative to double reading for detecting cancer in screening mammograms. The aim of this study is to investigate whether the use of a single reader with CAD is more cost-effective than double reading. Methods: Based on data from the CADET II study, the cost-effectiveness of single reading with CAD versus double reading was measured in terms of cost per cancer detected. Cost (Pound (£), year 2007/08) of single reading with CAD versus double reading was estimated assuming a health and social service perspective and a 7 year time horizon. As the equipment cost varies according to the unit size a separate analysis was conducted for high, average and low volume screening units. One-way sensitivity analyses were performed by varying the reading time, equipment and assessment cost, recall rate and reader qualification. Results: CAD is cost increasing for all sizes of screening unit. The introduction of CAD is cost-increasing compared to double reading because the cost of CAD equipment, staff training and the higher assessment cost associated with CAD are greater than the saving in reading costs. The introduction of single reading with CAD, in place of double reading, would produce an additional cost of £227 and £253 per 1,000 women screened in high and average volume units respectively. In low volume screening units, the high cost of purchasing the equipment will results in an additional cost of £590 per 1,000 women screened. One-way sensitivity analysis showed that the factors having the greatest effect on the cost-effectiveness of CAD with single reading compared with double reading were the reading time and the reader's professional qualification (radiologist versus advanced practitioner). Conclusions: Without improvements in CAD effectiveness (e.g. a decrease in the recall rate) CAD is unlikely to be a cost effective alternative to double reading for mammography screening in UK. This study provides updated estimates of CAD costs in a full-field digital system and assessment cost for women who are re-called after initial screening. However, the model is highly sensitive to various parameters e.g. reading time, reader qualification, and equipment cost. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
29. Policies to clean up toxic industrial contaminated sites of Gela and Priolo: a cost-benefit analysis.
- Author
-
Guerriero, Carla, Bianchi, Fabrizio, Cairns, John, and Cori, Liliana
- Subjects
- *
HAZARDOUS waste site remediation , *COST effectiveness , *INDUSTRIAL pollution , *PUBLIC health - Abstract
Background: Cost-benefit analysis is a transparent tool to inform policy makers about the potential effect of regulatory interventions, nevertheless its use to evaluate clean-up interventions in polluted industrial sites is limited. The two industrial areas of Gela and Priolo in Italy were declared "at high risk of environmental crisis" in 1990. Since then little has been done to clean the polluted sites and reduce the health outcomes attributable to pollution exposure. This study, aims to quantify the monetary benefits resulting from clean-up interventions in the contaminated sites of Gela and Priolo.Methods: A damage function approach was used to estimate the number of health outcomes attributable to industrial pollution exposure. Extensive one way analyses and probabilistic analyses were conducted to investigate the sensitivity of results to different model assumptions.Results: It has been estimated that, on average, 47 cases of premature death, 281 cases of cancer and 2,702 cases of non-cancer hospital admission could be avoided each year by removing environmental exposure in these two areas. Assuming a 20 year cessation lag and a 4% discount rate we calculate that the potential monetary benefit of removing industrial pollution is €3,592 million in Priolo and €6,639 million in Gela.Conclusions: Given the annual number of health outcomes attributable to pollution exposure the effective clean-up of Gela and Priolo should be prioritised. This study suggests that clean-up policies costing up to €6,639 million in Gela and €3,592 million in Priolo would be cost beneficial. These two amounts are notably higher than the funds allocated thus far to clean up the two sites, €127.4 million in Gela and €774.5 million in Priolo, implying that further economic investments - even considerable ones - could still prove cost beneficial. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
30. Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation.
- Author
-
Guerriero, Carla, Cairns, John, Jayaraman, Sudha, Roberts, Ian, Perel, Pablo, and Shakur, Haleema
- Subjects
- *
DRUG efficacy , *ANTIFIBRINOLYTIC agents , *HEMORRHAGE , *ELECTIVE surgery , *SURGICAL complications , *BLOOD transfusion - Abstract
Background: The identification of safe and effective alternatives to blood transfusion is a public health priority. In sub-Saharan Africa, blood shortage is a cause of mortality and morbidity. Blood transfusion can also transmit viral infections. Giving tranexamic acid (TXA) to bleeding surgical patients has been shown to reduce both the number of blood transfusions and the volume of blood transfused. The objective of this study is to investigate whether routinely administering TXA to bleeding elective surgical patients is cost effective by both averting deaths occurring from the shortage of blood, and by preventing infections from blood transfusions. Methods: A decision tree was constructed to evaluate the cost-effectiveness of providing TXA compared with no TXA in patients with surgical bleeding in four African countries with different human immunodeficiency virus (HIV) prevalence and blood donation rates (Kenya, South Africa, Tanzania and Botswana). The principal outcome measures were cost per life saved and cost per infection averted (HIV, Hepatitis B, Hepatitis C) averted in 2007 International dollars ($). The probability of receiving a blood transfusion with and without TXA and the risk of blood borne viral infection were estimated. The impact of uncertainty in model parameters was explored using one-way deterministic sensitivity analyses. Probabilistic sensitivity analysis was performed using Monte Carlo simulation. Results: The incremental cost per life saved is $87 for Kenya and $93 for Tanzania. In Botswana and South Africa, TXA administration is not life saving but is highly cost saving since fewer units of blood are transfused. Further, in Botswana the administration of TXA averts one case of HIV and four cases of Hepatitis B (HBV) per 1,000 surgical patients. In South Africa, one case of HBV is averted per 1,000 surgical patients. Probabilistic sensitivity analyses confirmed the robustness of the model. Conclusion: An economic argument can be made for giving TXA to bleeding elective surgical patients. In countries where there is a blood shortage, TXA would be a cost effective way to reduce mortality. In countries where there is no blood shortage, TXA would reduce healthcare costs and avert blood borne infections. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
31. newark: 11 memories.
- Author
-
Guerriero, Carla
- Subjects
- NEWARK: 11 Memories (Poem), GUERRIERO, Carla
- Abstract
Presents the poem "newark: 11 memories," by Carla Guerriero.
- Published
- 2002
32. the last eye-talian in town.
- Author
-
Guerriero, Carla
- Subjects
- LAST Eye-Talian in Town, The (Poem), GUERRIERO, Carla
- Abstract
Presents the poem "the last eye-talian in town," by Carla Guerriero.
- Published
- 2002
33. Represent Yourself in Court: How to Prepare and Try a Winning Case. 3d ed.
- Author
-
Guerriero, Carla
- Subjects
CIVIL procedure ,NONFICTION - Abstract
The article reviews the book "Represent Yourself in Court: How to Prepare and Try a Winning Case," 3d ed. by Paul Bergman and Sara Berman-Barrett.
- Published
- 2002
34. Human Rights in the United States: A Dictionary and Documents.
- Author
-
Guerriero, Carla
- Subjects
LAW ,NONFICTION - Abstract
The article reviews the book “Human Rights in the United States: A Dictionary and Documents,†by Rita Cantos Cartwright and H. Victor Condé.
- Published
- 2002
35. Hospitals' Strategic Behaviours and Patient Mobility: Evidence from Italy
- Author
-
Paolo Berta, Carla Guerriero, Rosella Levaggi, Berta P., Guerriero C., Levaggi R., Berta, Paolo, Guerriero, Carla, and Levaggi, Rosella
- Published
- 2021
36. Discounting benefits and costs
- Author
-
Carla Guerriero, Antonia Pacelli, carla guerriero, antonia pacelli, Guerriero, Carla, and Pacelli, Antonia
- Subjects
Discounting ,Section (archaeology) ,ComputerApplications_GENERAL ,Econometrics ,Economics ,Relevance (law) ,Constant (mathematics) - Abstract
This chapter provides considerations in a cost–benefit analysis (CBA) framework of different discounting methodologies. It discusses the main models developed for discounting: zero, constant, and declining discount rates. The chapter also summarizes existing evidence on the issues associated with the measurability of time preferences and intergenerational discounting. The last section analyzes the consequences arising from the use of discounting in CBA and discusses the relevance of the uncertainty in an intertemporal framework and its impacts on the results.
- Published
- 2020
37. Cost-Benefit Analysis of Environmental Health Interventions
- Author
-
Carla Guerriero and Guerriero, Carla
- Published
- 2020
38. Costing environmental health intervention
- Author
-
Carla Guerriero and Guerriero, Carla
- Subjects
Intervention (law) ,Time frame ,General equilibrium theory ,Section (archaeology) ,Environmental health ,Psychological intervention ,Economics ,Economic analysis ,Activity-based costing - Abstract
Estimating the costs associated with environmental health interventions (EHIs) is as difficult as estimating their benefits. The objective of this chapter is to provide an overview of the main issues associated with costing EHIs. The second section outlines the two approaches: financial and economic analysis to quantify the cost of EHIs. The third section is devoted to examining the differences between partial and general equilibrium analysis. The fourth section provides suggestions on selecting the appropriate time frame for estimating the costs by summarizing indications from existing cost–benefit analysis guidelines.
- Published
- 2020
39. Introduction
- Author
-
Carla Guerriero and Guerriero, Carla
- Published
- 2020
40. The key steps in cost–benefit analysis of environmental health interventions
- Author
-
Carla Guerriero and Guerriero, Carla
- Subjects
Intervention (law) ,Cost–benefit analysis ,Computer science ,Process (engineering) ,Environmental health ,Psychological intervention ,Key (cryptography) ,Decision problem ,Robustness (economics) ,Uncertainty analysis - Abstract
The objective of this chapter is to provide an overview of the different steps involved in the cost–benefit analysis of environmental health interventions. This chapter helps making the process of conducting a cost–benefit analysis more manageable by dividing the analysis into seven main consecutive steps: (1) specifying the decision problem, (2) quantifying the benefits, (3) assigning monetary values to each benefit, (4) quantifying the costs of the intervention, (5) including considerations of the life span for costs and benefits and reexpressing these as present values, (6) comparing the estimated costs with the benefits, and (7) performing uncertainty analysis to assess the robustness of the study results. The remaining part of this chapter will focus on a brief overview of each step with a special focus on Step 1, which is not covered in the remaining chapters of this book.
- Published
- 2020
41. Conclusion
- Author
-
Carla Guerriero, John S.F. Wright, Guerriero, Carla, and Wright, John S. F.
- Published
- 2020
42. The dog was acting: Designing an animation tool to enable children and young people to express their views about their health state
- Author
-
Carla Guerriero, Jo Wray, Neus Abrines, John Cairns, Joan Ashworth, Matt Abbiss, Katherine L Brown, Abbiss, Matt, Ashworth, Joan, Abrines, Neu, Cairns, John, Wray, Jo, Brown, Katherine, and Guerriero, Carla
- Subjects
Polymers and Plastics ,Computer science ,Human–computer interaction ,Animation ,State (computer science) ,General Environmental Science - Published
- 2017
43. The economic benefits of reducing the levels of nitrogen dioxide (NO2) near primary schools: The case of London
- Author
-
John Cairns, Lia Chatzidiakou, Dejan Mumovic, Carla Guerriero, Guerriero, Carla, Chatzidiakou, Lia, Cairns, John, and Mumovic, Dejan
- Subjects
School ,Male ,Environmental Engineering ,010504 meteorology & atmospheric sciences ,Monetary benefit ,Cost-Benefit Analysis ,Child Health Services ,Nitrogen Dioxide ,education ,010501 environmental sciences ,Health benefits ,Management, Monitoring, Policy and Law ,01 natural sciences ,complex mixtures ,Child health ,Health data ,Willingness to pay ,Environmental health ,London ,Humans ,Cost-Benefit Analysi ,Child ,Waste Management and Disposal ,0105 earth and related environmental sciences ,Primary school ,Nitrogen dioxide (NO2) ,Air Pollutants ,Asthma exacerbations ,Schools ,Environmental engineering ,General Medicine ,Economic benefits ,Asthma ,Children's health ,Air Pollutant ,Air Pollution, Indoor ,Economic evaluation ,Child Health Service ,School environment ,Female ,Business ,Human ,Environmental Monitoring - Abstract
Providing a healthy school environment is a priority for child health. The aim of this study is to develop a methodology that allows quantification of the potential economic benefit of reducing indoor exposure to nitrogen dioxide (NO2) in children attending primary schools. Using environmental and health data collected in primary schools in London, this study estimates that, on average, 82 asthma exacerbations per school can be averted each year by reducing outdoor NO2 concentrations. The study expands upon previous analyses in two ways: first it assesses the health benefits of reducing children’s exposure to indoor NO2 while at school, second it considers the children’s perspective in the economic evaluation. Using a willingness to pay approach, the study quantifies that the monetary benefits of reducing children’s indoor NO2 exposure while at school would range between £2.5 k per school if a child’s perspective based on child’s budget is adopted up to £60 k if a parent’s perspective is considered. This study highlights that designers, engineers, policymakers and stakeholders need to consider the reduction of outdoor pollution, and particularly NO2 levels, near primary schools as there may be substantial health and monetary benefits.
- Published
- 2016
44. A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial
- Author
-
David Inwald, Paddy McMaster, Peter-Marc Fortune, Carla Guerriero, Helen Betts, Diana Elbourne, Deborah Piercy, Richard Grieve, Roger C Parslow, Mark L Duthie, Claire Snowdon, Zia Sadique, Margrid Schindler, Elizabeth Allen, Robert C. Tasker, Zdenek Slavik, Kevin Morris, Mark J. Peters, Duncan Macrae, Vithayathil John Pappachan, Laura Van Dyck, Paul Baines, Michael Broadhead, Macrae, Duncan, Grieve, Richard, Allen, Elizabeth, Sadique, Zia, Betts, Helen, Morris, Kevin, Pappachan, Vithayathil John, Parslow, Roger, Tasker, Robert C., Baines, Paul, Broadhead, Michael, Duthie, Mark L., Fortune, Peter-Marc, Inwald, David, Mcmaster, Paddy, Peters, Mark J., Schindler, Margrid, Guerriero, Carla, Piercy, Deborah, Slavik, Zdenek, Snowdon, Claire, Van Dyck, Laura, and Elbourne, Diana
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,lcsh:Medical technology ,Adolescent ,medicine.medical_treatment ,Cost-Benefit Analysis ,Intensive Care Units, Pediatric ,law.invention ,Outcome Assessment (Health Care) ,Randomized controlled trial ,law ,Intensive care ,Diabetes mellitus ,Surveys and Questionnaires ,Outcome Assessment, Health Care ,medicine ,Surveys and Questionnaire ,Humans ,Hypoglycemic Agents ,Insulin ,Cost-Benefit Analysi ,Child ,Mechanical ventilation ,Hypoglycemic Agent ,business.industry ,Health Policy ,Infant ,Health Care Costs ,medicine.disease ,Confidence interval ,Cardiac surgery ,Health Care Cost ,lcsh:R855-855.5 ,England ,Child, Preschool ,Hyperglycemia ,Arterial line ,Female ,business ,Human ,Research Article - Abstract
Background Early research in adults admitted to intensive care suggested that tight control of blood glucose during acute illness can be associated with reductions in mortality, length of hospital stay and complications such as infection and renal failure. Prior to our study, it was unclear whether or not children could also benefit from tight control of blood glucose during critical illness. Objectives This study aimed to determine if controlling blood glucose using insulin in paediatric intensive care units (PICUs) reduces mortality and morbidity and is cost-effective, whether or not admission follows cardiac surgery. Design Randomised open two-arm parallel group superiority design with central randomisation with minimisation. Analysis was on an intention-to-treat basis. Following random allocation, care givers and outcome assessors were no longer blind to allocation. Setting The setting was 13 English PICUs. Participants Patients who met the following criteria were eligible for inclusion: ≥ 36 weeks corrected gestational age; ≤ 16 years; in the PICU following injury, following major surgery or with critical illness; anticipated treatment > 12 hours; arterial line; mechanical ventilation; and vasoactive drugs. Exclusion criteria were as follows: diabetes mellitus; inborn error of metabolism; treatment withdrawal considered; in the PICU > 5 consecutive days; and already in CHiP (Control of Hyperglycaemia in Paediatric intensive care). Intervention The intervention was tight glycaemic control (TGC): insulin by intravenous infusion titrated to maintain blood glucose between 4.0 and 7.0 mmol/l. Conventional management (CM) This consisted of insulin by intravenous infusion only if blood glucose exceeded 12.0 mmol/l on two samples at least 30 minutes apart; insulin was stopped when blood glucose fell below 10.0 mmol/l. Main outcome measures The primary outcome was the number of days alive and free from mechanical ventilation within 30 days of trial entry (VFD-30). The secondary outcomes comprised clinical and economic outcomes at 30 days and 12 months and lifetime cost-effectiveness, which included costs per quality-adjusted life-year. Results CHiP recruited from May 2008 to September 2011. In total, 19,924 children were screened and 1369 eligible patients were randomised (TGC, 694; CM, 675), 60% of whom were in the cardiac surgery stratum. The randomised groups were comparable at trial entry. More children in the TGC than in the CM arm received insulin (66% vs. 16%). The mean VFD-30 was 23 [mean difference 0.36; 95% confidence interval (CI) –0.42 to 1.14]. The effect did not differ among prespecified subgroups. Hypoglycaemia occurred significantly more often in the TGC than in the CM arm (moderate, 12.5% vs. 3.1%; severe, 7.3% vs. 1.5%). Mean 30-day costs were similar between arms, but mean 12-month costs were lower in the TGC than in CM arm (incremental costs –£3620, 95% CI –£7743 to £502). For the non-cardiac surgery stratum, mean costs were lower in the TGC than in the CM arm (incremental cost –£9865, 95% CI –£18,558 to –£1172), but, in the cardiac surgery stratum, the costs were similar between the arms (incremental cost £133, 95% CI –£3568 to £3833). Lifetime incremental net benefits were positive overall (£3346, 95% CI –£11,203 to £17,894), but close to zero for the cardiac surgery stratum (–£919, 95% CI –£16,661 to £14,823). For the non-cardiac surgery stratum, the incremental net benefits were high (£11,322, 95% CI –£15,791 to £38,615). The probability that TGC is cost-effective is relatively high for the non-cardiac surgery stratum, but, for the cardiac surgery subgroup, the probability that TGC is cost-effective is around 0.5. Sensitivity analyses showed that the results were robust to a range of alternative assumptions. Conclusions CHiP found no differences in the clinical or cost-effectiveness of TGC compared with CM overall, or for prespecified subgroups. A higher proportion of the TGC arm had hypoglycaemia. This study did not provide any evidence to suggest that PICUs should stop providing CM for children admitted to PICUs following cardiac surgery. For the subgroup not admitted for cardiac surgery, TGC reduced average costs at 12 months and is likely to be cost-effective. Further research is required to refine the TGC protocol to minimise the risk of hypoglycaemic episodes and assess the long-term health benefits of TGC. Trial registration Current Controlled Trials ISRCTN61735247. Funding This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 18, No. 26. See the NIHR Journals Library website for further project information.
- Published
- 2014
45. Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial
- Author
-
Carla Guerriero, John Cairns, Pablo Perel, Haleema Shakur, Ian Roberts, CRASH 2 trial collaborators, Guerriero, Carla, Cairns, John, Perel, Pablo, Shakur, Haleema, and Roberts, Ian
- Subjects
Pediatrics ,Critical Care and Emergency Medicine ,Cost effectiveness ,Cost-Benefit Analysis ,Global Health ,Tanzania ,Science Policy and Economics ,Antifibrinolytic agent ,Outcome Assessment, Health Care ,health care economics and organizations ,Multidisciplinary ,biology ,Cost–benefit analysis ,Drug Information ,Cost-effectiveness analysis ,Middle Aged ,Antifibrinolytic Agents ,Markov Chains ,Pharmacoeconomics ,Hospitalization ,Tranexamic Acid ,Medicine ,Perioperative Critical Care ,Public Health ,Tranexamic acid ,medicine.drug ,Human ,Research Article ,Adult ,Risk ,medicine.medical_specialty ,Drugs and Devices ,Adolescent ,Clinical Research Design ,Science Policy ,Science ,Fluid Management ,Trauma Surgery ,India ,Hemorrhage ,Antifibrinolytic Agent ,Outcome Assessment (Health Care) ,medicine ,Humans ,Clinical Trials ,Cost-Benefit Analysi ,Cost database ,Probability ,Biochemistry, Genetics and Molecular Biology (all) ,Models, Statistical ,business.industry ,Modeling ,Drug Policy ,Markov Chain ,Models, Theoretical ,biology.organism_classification ,United Kingdom ,Clinical trial ,Agricultural and Biological Sciences (all) ,Emergency medicine ,Surgery ,business - Abstract
ObjectiveTo assess the cost effectiveness of giving tranexamic acid (TXA) to bleeding trauma patients in low, middle and high income settings.MethodsThe CRASH-2 trial showed that TXA administration reduces the risk of death in bleeding trauma patients with a small but statistically significant increase in non-intensive care stay. A Markov model was used to assess the cost effectiveness of TXA in Tanzania, India and the United Kingdom (UK). The health outcome was the number of life years gained (LYs). Two costs were considered: the cost of administering TXA and the cost of additional days in hospital. Cost data were obtained from hospitals, World Health Organization (WHO) database and UK reference costs. Cost-effectiveness was measured in international dollars ($) per LY. Both deterministic and probabilistic sensitivity analyses were performed to test the robustness of the results to model assumptions.FindingsAdministering TXA to bleeding trauma patients within three hours of injury saved an estimated 372, 315 and 755 LYs per 1,000 trauma patients in Tanzania, India and the UK respectively. The cost of giving TXA to 1,000 patients was $17,483 in Tanzania, $19,550 in India and $30,830 in the UK. The incremental cost of giving TXA versus not giving TXA was $18,025 in Tanzania, $20,670 in India and $48,002 in the UK. The estimated incremental cost per LY gained of administering TXA is $48, $66 and $64 in Tanzania, India and the UK respectively.ConclusionEarly administration of TXA to bleeding trauma patients is likely to be highly cost effective in low, middle and high income settings.Trial registrationThis paper uses data collected by the CRASH 2 trial: Controlled-Trials.com ISRCTN86750102, Clinicaltrials.govNCT00375258 and South African Clinical Trial Register DOH-27-0607-1919.
- Published
- 2011
46. Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy
- Author
-
Frank Romeo, Alfredo Mazza, Carla Guerriero, Marco G. Paggi, Pasquale Maranta, Antonio Giordano, Ignazio R. Marino, Massimo Di Maio, Maddalena Barba, Barba, Maddalena, Mazza, Alfredo, Guerriero, Carla, DI MAIO, Massimo, Romeo, Frank, Maranta, Pasquale, Marino, Ignazio R., Paggi, Marco G., and Giordano, Antonio
- Subjects
Cancer Research ,Hazardous Waste ,Health outcome ,Geographical studie ,Industrial Waste ,Context (language use) ,Review ,Health outcomes ,Toxic waste ,Scientific evidence ,Environmental protection ,Risk Factors ,Environmental health ,Neoplasms ,Dumping ,medicine ,Humans ,Wasting ,Dumping site ,Pharmacology ,Environmental Exposure ,Economic benefits ,Oncology ,Italy ,Health ,Biomonitoring ,Molecular Medicine ,Business ,medicine.symptom ,Exposure data ,Economic studie - Abstract
Three decades of illegal practices of waste dumping and consequent environmental abuse have made the Campania region of Southern Italy a unique case in the context of waste-related health outcomes. Scientific evidence is mounting in support of a significant increase in cancer mortality and malformation occurrence in specific areas of the Campania region, where improper waste management and illegal waste trafficking have been repeatedly documented. However, the currently available evidence suffers from limitations mainly due to study design, lack of consideration of confounders and quality of the exposure data. Recent economic studies have shown the economic benefits of reclaiming toxic waste sites in Campania. Future perspectives include the adoption of different study designs, use of biomarkers and a molecular approach. Current knowledge, both scientific and economic, might be of help in orienting the short and long term governmental policy on waste related health outcomes at a regional level.
- Published
- 2011
47. The risk of transfusion-transmitted infections in sub-Saharan Africa
- Author
-
Sudha Jayaraman, Pablo Perel, Ian Roberts, Carla Guerriero, Zaid Chalabi, Jayaraman, Sudha, Chalabi, Zaid, Perel, Pablo, Guerriero, Carla, and Roberts, Ian
- Subjects
Risk ,Blood transfusion ,medicine.medical_treatment ,Hepatitis C virus ,Immunology ,Blood Donors ,HIV Infections ,medicine.disease_cause ,Sensitivity and Specificity ,Environmental health ,Disease Transmission, Infectious ,Prevalence ,Medicine ,Humans ,Mass Screening ,Immunology and Allergy ,HIV Infection ,Viremia ,Risk factor ,False Negative Reactions ,Africa South of the Sahara ,Probability ,Hepatitis B virus ,business.industry ,Transmission (medicine) ,Blood Donor ,Incidence (epidemiology) ,Incidence ,Transfusion Reaction ,Hepatitis C ,Hematology ,Hepatitis B ,Models, Theoretical ,medicine.disease ,False Negative Reaction ,Algorithm ,Disease Transmission, Infectiou ,Disease Susceptibility ,business ,Algorithms ,Human - Abstract
BACKGROUND: Blood transfusions carry the risk of transmitting infections. This risk has been studied in detail in high-income countries but not in sub-Saharan Africa. This study estimates the risks of acquiring human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) from a single unit of blood in sub-Saharan Africa. STUDY DESIGN AND METHODS: A mathematical model was constructed to quantify transfusion risks across 45 sub-Saharan African countries using three components: the risk of a contaminated unit entering the blood supply, the risk that the unit will be given to a susceptible patient, and the risk that receipt of the unit will lead to infection in the recipient. Variables included prevalence of infection in donors, extent of blood testing, test sensitivity, and susceptibility of recipients. Data from the World Health Organization (WHO) African Region and a systematic review of the literature were used to parameterize the model. Uncertainty in the risk estimates was quantified using probabilistic sensitivity analysis. RESULTS: The median overall risks of becoming infected with HIV, HBV, and HCV from a blood transfusion in sub-Saharan Africa were 1, 4.3, and 2.5 infections per 1000 units, respectively. If annual transfusion requirements projected by the WHO were met, transfusions alone would be responsible for 28,595 HBV infections, 16,625 HCV infections, and 6650 HIV infections every year. Sensitivity analysis suggests that the true risks may be even higher. CONCLUSIONS: This study is the first to systematically quantify the risks of transfusion-transmitted infections across sub-Saharan Africa. Although the results are limited by the quality and quantity of available data, these may be the most reliable estimates at this time.
- Published
- 2010
48. Erratum: Author Correction: Health and sustainability in post-pandemic economic policies.
- Author
-
Guerriero C, Haines A, and Pagano M
- Abstract
[This corrects the article DOI: 10.1038/s41893-020-0563-0.]., (© Springer Nature Limited 2020.)
- Published
- 2020
- Full Text
- View/download PDF
49. A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial.
- Author
-
Macrae D, Grieve R, Allen E, Sadique Z, Betts H, Morris K, Pappachan VJ, Parslow R, Tasker RC, Baines P, Broadhead M, Duthie ML, Fortune PM, Inwald D, McMaster P, Peters MJ, Schindler M, Guerriero C, Piercy D, Slavik Z, Snowdon C, Van Dyck L, and Elbourne D
- Subjects
- Adolescent, Child, Child, Preschool, England, Female, Health Care Costs statistics & numerical data, Humans, Hyperglycemia economics, Hypoglycemic Agents therapeutic use, Infant, Insulin therapeutic use, Male, Outcome Assessment, Health Care, Surveys and Questionnaires, Cost-Benefit Analysis, Hyperglycemia drug therapy, Hypoglycemic Agents economics, Insulin economics, Intensive Care Units, Pediatric economics
- Abstract
Background: Early research in adults admitted to intensive care suggested that tight control of blood glucose during acute illness can be associated with reductions in mortality, length of hospital stay and complications such as infection and renal failure. Prior to our study, it was unclear whether or not children could also benefit from tight control of blood glucose during critical illness., Objectives: This study aimed to determine if controlling blood glucose using insulin in paediatric intensive care units (PICUs) reduces mortality and morbidity and is cost-effective, whether or not admission follows cardiac surgery., Design: Randomised open two-arm parallel group superiority design with central randomisation with minimisation. Analysis was on an intention-to-treat basis. Following random allocation, care givers and outcome assessors were no longer blind to allocation., Setting: The setting was 13 English PICUs., Participants: Patients who met the following criteria were eligible for inclusion: ≥ 36 weeks corrected gestational age; ≤ 16 years; in the PICU following injury, following major surgery or with critical illness; anticipated treatment > 12 hours; arterial line; mechanical ventilation; and vasoactive drugs. Exclusion criteria were as follows: diabetes mellitus; inborn error of metabolism; treatment withdrawal considered; in the PICU > 5 consecutive days; and already in CHiP (Control of Hyperglycaemia in Paediatric intensive care)., Intervention: The intervention was tight glycaemic control (TGC): insulin by intravenous infusion titrated to maintain blood glucose between 4.0 and 7.0 mmol/l., Conventional Management (cm): This consisted of insulin by intravenous infusion only if blood glucose exceeded 12.0 mmol/l on two samples at least 30 minutes apart; insulin was stopped when blood glucose fell below 10.0 mmol/l., Main Outcome Measures: The primary outcome was the number of days alive and free from mechanical ventilation within 30 days of trial entry (VFD-30). The secondary outcomes comprised clinical and economic outcomes at 30 days and 12 months and lifetime cost-effectiveness, which included costs per quality-adjusted life-year., Results: CHiP recruited from May 2008 to September 2011. In total, 19,924 children were screened and 1369 eligible patients were randomised (TGC, 694; CM, 675), 60% of whom were in the cardiac surgery stratum. The randomised groups were comparable at trial entry. More children in the TGC than in the CM arm received insulin (66% vs. 16%). The mean VFD-30 was 23 [mean difference 0.36; 95% confidence interval (CI) -0.42 to 1.14]. The effect did not differ among prespecified subgroups. Hypoglycaemia occurred significantly more often in the TGC than in the CM arm (moderate, 12.5% vs. 3.1%; severe, 7.3% vs. 1.5%). Mean 30-day costs were similar between arms, but mean 12-month costs were lower in the TGC than in CM arm (incremental costs -£3620, 95% CI -£7743 to £502). For the non-cardiac surgery stratum, mean costs were lower in the TGC than in the CM arm (incremental cost -£9865, 95% CI -£18,558 to -£1172), but, in the cardiac surgery stratum, the costs were similar between the arms (incremental cost £133, 95% CI -£3568 to £3833). Lifetime incremental net benefits were positive overall (£3346, 95% CI -£11,203 to £17,894), but close to zero for the cardiac surgery stratum (-£919, 95% CI -£16,661 to £14,823). For the non-cardiac surgery stratum, the incremental net benefits were high (£11,322, 95% CI -£15,791 to £38,615). The probability that TGC is cost-effective is relatively high for the non-cardiac surgery stratum, but, for the cardiac surgery subgroup, the probability that TGC is cost-effective is around 0.5. Sensitivity analyses showed that the results were robust to a range of alternative assumptions., Conclusions: CHiP found no differences in the clinical or cost-effectiveness of TGC compared with CM overall, or for prespecified subgroups. A higher proportion of the TGC arm had hypoglycaemia. This study did not provide any evidence to suggest that PICUs should stop providing CM for children admitted to PICUs following cardiac surgery. For the subgroup not admitted for cardiac surgery, TGC reduced average costs at 12 months and is likely to be cost-effective. Further research is required to refine the TGC protocol to minimise the risk of hypoglycaemic episodes and assess the long-term health benefits of TGC., Trial Registration: Current Controlled Trials ISRCTN61735247., Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 18, No. 26. See the NIHR Journals Library website for further project information.
- Published
- 2014
- Full Text
- View/download PDF
50. The potential monetary benefits of reclaiming hazardous waste sites in the Campania region: an economic evaluation.
- Author
-
Guerriero C and Cairns J
- Subjects
- Female, Health Care Costs statistics & numerical data, Humans, Italy, Male, Mortality, Neoplasms mortality, Conservation of Natural Resources economics, Environmental Exposure economics, Environmental Exposure statistics & numerical data, Hazardous Waste economics, Refuse Disposal economics
- Abstract
Background: Evaluating the economic benefit of reducing negative health outcomes resulting from waste management is of pivotal importance for designing an effective waste policy that takes into account the health consequences for the populations exposed to environmental hazards. Despite the high level of Italian and international media interest in the problem of hazardous waste in Campania little has been done to reclaim the land and the waterways contaminated by hazardous waste., Objective: This study aims to reduce the uncertainty about health damage due to waste exposure by providing for the first time a monetary valuation of health benefits arising from the reclamation of hazardous waste dumps in Campania., Methods: First the criteria by which the landfills in the Campania region, in particular in the two provinces of Naples and Caserta, have been classified are described. Then, the annual cases of premature death and fatal cases of cancers attributable to waste exposure are quantified. Finally, the present value of the health benefits from the reclamation of polluted land is estimated for each of the health outcomes (premature mortality, fatal cancer and premature mortality adjusted for the cancer premium). Due to the uncertainty about the time frame of the benefits arising from reclamation, the latency of the effects of toxic waste on human health and the lack of context specific estimates of the Value of Preventing a Fatality (VPF), extensive sensitivity analyses are performed., Results: There are estimated to be 848 cases of premature mortality and 403 cases of fatal cancer per year as a consequence of exposure to toxic waste. The present value of the benefit of reducing the number of waste associated deaths after adjusting for a cancer premium is euro11.6 billion. This value ranges from euro5.4 to euro20.0 billion assuming a time frame for benefits of 10 and 50 years respectively., Conclusion: This study suggests that there is a strong economic argument for both reclaiming the land contaminated with hazardous waste in the two provinces of Naples and Caserta and increasing the control of the territory in order to avoid the creation of new illegal dump sites.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.